Search Results

You are looking at 1 - 10 of 205 items for :

  • "lymph node dissection" x
  • Refine by Access: All x
Clear All
Full access

George Plitas and Charlotte E. Ariyan

melanoma has been guided by many multicenter randomized trials that have shaped management decisions. Treatment has evolved from elective lymph node dissections to newer strategies identifying the most at-risk patients through sentinel lymph node (SLN

Full access

Elizabeth G. Grubbs and Douglas B. Evans

extensive lymph node dissection: metastatic lymph nodes in papillary carcinoma of the thyroid] . Nippon Geka Gakkai Zasshi 1986 ; 87 : 883 – 888 [in Japanese] . 5. Tisell LE Nilsson B Molne J . Improved survival of patients with papillary

Full access

Nawin Kuntaraksa

Objective: The primary objective was to evaluate seroma formation in a comparison between the lymphatic ligation technique and conventional axillary lymph node dissection. The secondary objective was to evaluate the factors affecting seroma

Full access

Kevin Zhang, Ladan Navari, Amy Li, Sandy Lee, Yevgeniya Gokun, Min-Jeong Cho, Roman Skoracki, and Ko Un Park

INTRODUCTION : Up to 40% of patients after axillary lymph node dissection (ALND) develop breast cancer related lymphedema (BCRL), which has significant medical, financial, and psychosocial implications. NCCN guideline recommends referral to

Full access

James Sun, Brittany J. Mathias, Christine Laronga, Weihong Sun, Jun-Min Zhou, William J. Fulp, John V. Kiluk, and M. Catherine Lee

Background Surgical management of invasive breast cancer has moved toward less-invasive measures, including axillary management. Axillary lymph node dissection is associated with significant morbidity and complications (wound infections, seromas

Full access

Donglai Chen, Yiming Mao, Junmiao Wen, Jian Shu, Fei Ye, Yunlang She, Qifeng Ding, Li Shi, Tao Xue, Min Fan, Yongbing Chen, and Chang Chen

based on several studies suggested that lobe-specific lymph node dissection (LSD) is equivalent to SLND in early-stage NSCLC. 14 , 16 , 17 Therefore, it is important to determine the threshold of ELNs and ENSs for early-stage NSCLC, especially for

Full access

Anthony J. Olszanski

biopsy. After a diagnosis of stage III disease based on SLN biopsy, the previous version of the NCCN Guidelines stated that these patients should undergo complete lymph node dissection (CLND). “’The questions we had to ask were, ‘Is that something we

Full access

Anupam Rishi, Jordan McDonald, Sabrina Saeed, Rutika Mehta, David Pointer, Jessica Frakes, Sarah Hoffe, Jacques Fontaine, and Jose Pimiento

Full access

Jaffer A. Ajani, David J. Bentrem, Stephen Besh, Thomas A. D’Amico, Prajnan Das, Crystal Denlinger, Marwan G. Fakih, Charles S. Fuchs, Hans Gerdes, Robert E. Glasgow, James A. Hayman, Wayne L. Hofstetter, David H. Ilson, Rajesh N. Keswani, Lawrence R. Kleinberg, W. Michael Korn, A. Craig Lockhart, Kenneth Meredith, Mary F. Mulcahy, Mark B. Orringer, James A. Posey, Aaron R. Sasson, Walter J. Scott, Vivian E. Strong, Thomas K. Varghese Jr, Graham Warren, Mary Kay Washington, Christopher Willett, Cameron D. Wright, Nicole R. McMillian, and Hema Sundar

second most common cause of cancer-related death worldwide. In 2013, an estimated 21,600 new cases will be diagnosed and 10,990 people will die of the disease in United States. 1 Surgery with lymph node dissection is the primary treatment for patients

Full access

William C. Huang and Bernard H. Bochner

Gschwend JE Herr HW . Pelvic lymph node dissection can be curative in patients with node positive bladder cancer . J Urol 1999 ; 161 : 449 – 454 . 7. Leissner J Ghoneim MA Abol-Enein H . Extended radical lymphadenectomy in patients with